Global Orphan Diseases Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

August 2018 | 122 pages | ID: GC5BDFDE2DBGEN
GlobalInfoResearch

Abstracts

An orphan disease is defined as a condition that affects fewer than 200,000 people nationwide. This includes diseases as familiar as cystic fibrosis, Lou Gehrig's disease, and Tourette's syndrome, and as unfamiliar as Hamburger disease, Job syndrome, and acromegaly, or 'gigantism.' Some diseases have patient populations of fewer than a hundred.

SCOPE OF THE REPORT:

This report studies the Orphan Diseases market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Orphan Diseases market by product type and applications/end industries.
New rare diseases are discovered every year. Most are inherited and caused by alterations or defects in genes (mutations). Others can be acquired as a result of environmental and toxic conditions. Genes are pieces of DNA, part of the code that determines the traits and individual characteristics of all living things.
The global Orphan Diseases market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Orphan Diseases.

Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.

Market Segment by Companies, this report covers

• Bristol-Myers Squibb
• Novartis
• Celgene
• Roche
• Pfizer
• Alexion
• Sanofi
• Vertex Pharmaceuticals
• GlaxoSmithKline
• Merck
• Abbvie

Market Segment by Regions, regional analysis covers

• North America (United States, Canada and Mexico)
• Europe (Germany, France, UK, Russia and Italy)
• Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
• South America (Brazil, Argentina, Colombia)
• Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

• Autoimmune Disorders
• Genetic Disorders
• Blood Disorders
• Cancer
• Growth Disorder
• Cardiovascular Diseases
• Neurological Disorders
• Respiratory Disorders
• Digestive Disorders
• Eye Disorders

Market Segment by Applications, can be divided into

• Hospitals And Clinics
• Research Laboratories

Contents

1 ORPHAN DISEASES MARKET OVERVIEW

1.1 Product Overview and Scope of Orphan Diseases
1.2 Classification of Orphan Diseases by Types
  1.2.1 Global Orphan Diseases Revenue Comparison by Types (2017-2023)
  1.2.2 Global Orphan Diseases Revenue Market Share by Types in 2017
  1.2.3 Autoimmune Disorders
  1.2.4 Genetic Disorders
  1.2.5 Blood Disorders
  1.2.6 Cancer
  1.2.7 Growth Disorder
  1.2.8 Cardiovascular Diseases
  1.2.9 Neurological Disorders
  1.2.10 Respiratory Disorders
  1.2.11 Digestive Disorders
  1.2.12 Eye Disorders
1.3 Global Orphan Diseases Market by Application
  1.3.1 Global Orphan Diseases Market Size and Market Share Comparison by Applications (2013-2023)
  1.3.2 Hospitals And Clinics
  1.3.3 Research Laboratories
1.4 Global Orphan Diseases Market by Regions
  1.4.1 Global Orphan Diseases Market Size (Million USD) Comparison by Regions (2013-2023)
  1.4.1 North America (USA, Canada and Mexico) Orphan Diseases Status and Prospect (2013-2023)
  1.4.2 Europe (Germany, France, UK, Russia and Italy) Orphan Diseases Status and Prospect (2013-2023)
  1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Orphan Diseases Status and Prospect (2013-2023)
  1.4.4 South America (Brazil, Argentina, Colombia) Orphan Diseases Status and Prospect (2013-2023)
  1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Orphan Diseases Status and Prospect (2013-2023)
1.5 Global Market Size of Orphan Diseases (2013-2023)

2 MANUFACTURERS PROFILES

2.1 Bristol-Myers Squibb
  2.1.1 Business Overview
  2.1.2 Orphan Diseases Type and Applications
    2.1.2.1 Product A
    2.1.2.2 Product B
  2.1.3 Bristol-Myers Squibb Orphan Diseases Revenue, Gross Margin and Market Share (2016-2017)
2.2 Novartis
  2.2.1 Business Overview
  2.2.2 Orphan Diseases Type and Applications
    2.2.2.1 Product A
    2.2.2.2 Product B
  2.2.3 Novartis Orphan Diseases Revenue, Gross Margin and Market Share (2016-2017)
2.3 Celgene
  2.3.1 Business Overview
  2.3.2 Orphan Diseases Type and Applications
    2.3.2.1 Product A
    2.3.2.2 Product B
  2.3.3 Celgene Orphan Diseases Revenue, Gross Margin and Market Share (2016-2017)
2.4 Roche
  2.4.1 Business Overview
  2.4.2 Orphan Diseases Type and Applications
    2.4.2.1 Product A
    2.4.2.2 Product B
  2.4.3 Roche Orphan Diseases Revenue, Gross Margin and Market Share (2016-2017)
2.5 Pfizer
  2.5.1 Business Overview
  2.5.2 Orphan Diseases Type and Applications
    2.5.2.1 Product A
    2.5.2.2 Product B
  2.5.3 Pfizer Orphan Diseases Revenue, Gross Margin and Market Share (2016-2017)
2.6 Alexion
  2.6.1 Business Overview
  2.6.2 Orphan Diseases Type and Applications
    2.6.2.1 Product A
    2.6.2.2 Product B
  2.6.3 Alexion Orphan Diseases Revenue, Gross Margin and Market Share (2016-2017)
2.7 Sanofi
  2.7.1 Business Overview
  2.7.2 Orphan Diseases Type and Applications
    2.7.2.1 Product A
    2.7.2.2 Product B
  2.7.3 Sanofi Orphan Diseases Revenue, Gross Margin and Market Share (2016-2017)
2.8 Vertex Pharmaceuticals
  2.8.1 Business Overview
  2.8.2 Orphan Diseases Type and Applications
    2.8.2.1 Product A
    2.8.2.2 Product B
  2.8.3 Vertex Pharmaceuticals Orphan Diseases Revenue, Gross Margin and Market Share (2016-2017)
2.9 GlaxoSmithKline
  2.9.1 Business Overview
  2.9.2 Orphan Diseases Type and Applications
    2.9.2.1 Product A
    2.9.2.2 Product B
  2.9.3 GlaxoSmithKline Orphan Diseases Revenue, Gross Margin and Market Share (2016-2017)
2.10 Merck
  2.10.1 Business Overview
  2.10.2 Orphan Diseases Type and Applications
    2.10.2.1 Product A
    2.10.2.2 Product B
  2.10.3 Merck Orphan Diseases Revenue, Gross Margin and Market Share (2016-2017)
2.11 Abbvie
  2.11.1 Business Overview
  2.11.2 Orphan Diseases Type and Applications
    2.11.2.1 Product A
    2.11.2.2 Product B
  2.11.3 Abbvie Orphan Diseases Revenue, Gross Margin and Market Share (2016-2017)

3 GLOBAL ORPHAN DISEASES MARKET COMPETITION, BY PLAYERS

3.1 Global Orphan Diseases Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
  3.2.1 Top 5 Orphan Diseases Players Market Share
  3.2.2 Top 10 Orphan Diseases Players Market Share
3.3 Market Competition Trend

4 GLOBAL ORPHAN DISEASES MARKET SIZE BY REGIONS

4.1 Global Orphan Diseases Revenue and Market Share by Regions
4.2 North America Orphan Diseases Revenue and Growth Rate (2013-2018)
4.3 Europe Orphan Diseases Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Orphan Diseases Revenue and Growth Rate (2013-2018)
4.5 South America Orphan Diseases Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Orphan Diseases Revenue and Growth Rate (2013-2018)

5 NORTH AMERICA ORPHAN DISEASES REVENUE BY COUNTRIES

5.1 North America Orphan Diseases Revenue by Countries (2013-2018)
5.2 USA Orphan Diseases Revenue and Growth Rate (2013-2018)
5.3 Canada Orphan Diseases Revenue and Growth Rate (2013-2018)
5.4 Mexico Orphan Diseases Revenue and Growth Rate (2013-2018)

6 EUROPE ORPHAN DISEASES REVENUE BY COUNTRIES

6.1 Europe Orphan Diseases Revenue by Countries (2013-2018)
6.2 Germany Orphan Diseases Revenue and Growth Rate (2013-2018)
6.3 UK Orphan Diseases Revenue and Growth Rate (2013-2018)
6.4 France Orphan Diseases Revenue and Growth Rate (2013-2018)
6.5 Russia Orphan Diseases Revenue and Growth Rate (2013-2018)
6.6 Italy Orphan Diseases Revenue and Growth Rate (2013-2018)

7 ASIA-PACIFIC ORPHAN DISEASES REVENUE BY COUNTRIES

7.1 Asia-Pacific Orphan Diseases Revenue by Countries (2013-2018)
7.2 China Orphan Diseases Revenue and Growth Rate (2013-2018)
7.3 Japan Orphan Diseases Revenue and Growth Rate (2013-2018)
7.4 Korea Orphan Diseases Revenue and Growth Rate (2013-2018)
7.5 India Orphan Diseases Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Orphan Diseases Revenue and Growth Rate (2013-2018)

8 SOUTH AMERICA ORPHAN DISEASES REVENUE BY COUNTRIES

8.1 South America Orphan Diseases Revenue by Countries (2013-2018)
8.2 Brazil Orphan Diseases Revenue and Growth Rate (2013-2018)
8.3 Argentina Orphan Diseases Revenue and Growth Rate (2013-2018)
8.4 Colombia Orphan Diseases Revenue and Growth Rate (2013-2018)

9 MIDDLE EAST AND AFRICA REVENUE ORPHAN DISEASES BY COUNTRIES

9.1 Middle East and Africa Orphan Diseases Revenue by Countries (2013-2018)
9.2 Saudi Arabia Orphan Diseases Revenue and Growth Rate (2013-2018)
9.3 UAE Orphan Diseases Revenue and Growth Rate (2013-2018)
9.4 Egypt Orphan Diseases Revenue and Growth Rate (2013-2018)
9.5 Nigeria Orphan Diseases Revenue and Growth Rate (2013-2018)
9.6 South Africa Orphan Diseases Revenue and Growth Rate (2013-2018)

10 GLOBAL ORPHAN DISEASES MARKET SEGMENT BY TYPE

10.1 Global Orphan Diseases Revenue and Market Share by Type (2013-2018)
10.2 Global Orphan Diseases Market Forecast by Type (2018-2023)
10.3 Autoimmune Disorders Revenue Growth Rate (2013-2023)
10.4 Genetic Disorders Revenue Growth Rate (2013-2023)
10.5 Blood Disorders Revenue Growth Rate (2013-2023)
10.6 Cancer Revenue Growth Rate (2013-2023)
10.7 Growth Disorder Revenue Growth Rate (2013-2023)
10.8 Cardiovascular Diseases Revenue Growth Rate (2013-2023)
10.9 Neurological Disorders Revenue Growth Rate (2013-2023)
10.10 Respiratory Disorders Revenue Growth Rate (2013-2023)
10.11 Digestive Disorders Revenue Growth Rate (2013-2023)
10.12 Eye Disorders Revenue Growth Rate (2013-2023)

11 GLOBAL ORPHAN DISEASES MARKET SEGMENT BY APPLICATION

11.1 Global Orphan Diseases Revenue Market Share by Application (2013-2018)
11.2 Orphan Diseases Market Forecast by Application (2018-2023)
11.3 Hospitals And Clinics Revenue Growth (2013-2018)
11.4 Research Laboratories Revenue Growth (2013-2018)

12 GLOBAL ORPHAN DISEASES MARKET SIZE FORECAST (2018-2023)

12.1 Global Orphan Diseases Market Size Forecast (2018-2023)
12.2 Global Orphan Diseases Market Forecast by Regions (2018-2023)
12.3 North America Orphan Diseases Revenue Market Forecast (2018-2023)
12.4 Europe Orphan Diseases Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Orphan Diseases Revenue Market Forecast (2018-2023)
12.6 South America Orphan Diseases Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Orphan Diseases Revenue Market Forecast (2018-2023)

13 RESEARCH FINDINGS AND CONCLUSION

14 APPENDIX

14.1 Methodology
14.2 Data Source

List Of Tables

LIST OF TABLES AND FIGURES

Figure Orphan Diseases Picture
Table Product Specifications of Orphan Diseases
Table Global Orphan Diseases and Revenue (Million USD) Market Split by Product Type
Figure Global Orphan Diseases Revenue Market Share by Types in 2017
Figure Autoimmune Disorders Picture
Figure Genetic Disorders Picture
Figure Blood Disorders Picture
Figure Cancer Picture
Figure Growth Disorder Picture
Figure Cardiovascular Diseases Picture
Figure Neurological Disorders Picture
Figure Respiratory Disorders Picture
Figure Digestive Disorders Picture
Figure Eye Disorders Picture
Table Global Orphan Diseases Revenue (Million USD) by Application (2013-2023)
Figure Orphan Diseases Revenue Market Share by Applications in 2017
Figure Hospitals And Clinics Picture
Figure Research Laboratories Picture
Table Global Market Orphan Diseases Revenue (Million USD) Comparison by Regions 2013-2023
Figure North America Orphan Diseases Revenue (Million USD) and Growth Rate (2013-2023)
Figure Europe Orphan Diseases Revenue (Million USD) and Growth Rate (2013-2023)
Figure Asia-Pacific Orphan Diseases Revenue (Million USD) and Growth Rate (2013-2023)
Figure South America Orphan Diseases Revenue (Million USD) and Growth Rate (2013-2023)
Figure Middle East and Africa Orphan Diseases Revenue (Million USD) and Growth Rate (2013-2023)
Figure Global Orphan Diseases Revenue (Million USD) and Growth Rate (2013-2023)
Table Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors
Table Bristol-Myers Squibb Orphan Diseases Type and Applications
Table Bristol-Myers Squibb Orphan Diseases Revenue, Gross Margin and Market Share (2016-2017)
Table Novartis Basic Information, Manufacturing Base and Competitors
Table Novartis Orphan Diseases Type and Applications
Table Novartis Orphan Diseases Revenue, Gross Margin and Market Share (2016-2017)
Table Celgene Basic Information, Manufacturing Base and Competitors
Table Celgene Orphan Diseases Type and Applications
Table Celgene Orphan Diseases Revenue, Gross Margin and Market Share (2016-2017)
Table Roche Basic Information, Manufacturing Base and Competitors
Table Roche Orphan Diseases Type and Applications
Table Roche Orphan Diseases Revenue, Gross Margin and Market Share (2016-2017)
Table Pfizer Basic Information, Manufacturing Base and Competitors
Table Pfizer Orphan Diseases Type and Applications
Table Pfizer Orphan Diseases Revenue, Gross Margin and Market Share (2016-2017)
Table Alexion Basic Information, Manufacturing Base and Competitors
Table Alexion Orphan Diseases Type and Applications
Table Alexion Orphan Diseases Revenue, Gross Margin and Market Share (2016-2017)
Table Sanofi Basic Information, Manufacturing Base and Competitors
Table Sanofi Orphan Diseases Type and Applications
Table Sanofi Orphan Diseases Revenue, Gross Margin and Market Share (2016-2017)
Table Vertex Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Vertex Pharmaceuticals Orphan Diseases Type and Applications
Table Vertex Pharmaceuticals Orphan Diseases Revenue, Gross Margin and Market Share (2016-2017)
Table GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table GlaxoSmithKline Orphan Diseases Type and Applications
Table GlaxoSmithKline Orphan Diseases Revenue, Gross Margin and Market Share (2016-2017)
Table Merck Basic Information, Manufacturing Base and Competitors
Table Merck Orphan Diseases Type and Applications
Table Merck Orphan Diseases Revenue, Gross Margin and Market Share (2016-2017)
Table Abbvie Basic Information, Manufacturing Base and Competitors
Table Abbvie Orphan Diseases Type and Applications
Table Abbvie Orphan Diseases Revenue, Gross Margin and Market Share (2016-2017)
Table Global Orphan Diseases Revenue (Million USD) by Players (2013-2018)
Table Global Orphan Diseases Revenue Share by Players (2013-2018)
Figure Global Orphan Diseases Revenue Share by Players in 2016
Figure Global Orphan Diseases Revenue Share by Players in 2017
Figure Global Top 5 Players Orphan Diseases Revenue Market Share in 2017
Figure Global Top 10 Players Orphan Diseases Revenue Market Share in 2017
Figure Global Orphan Diseases Revenue (Million USD) and Growth Rate (%) (2013-2018)
Table Global Orphan Diseases Revenue (Million USD) by Regions (2013-2018)
Table Global Orphan Diseases Revenue Market Share by Regions (2013-2018)
Figure Global Orphan Diseases Revenue Market Share by Regions (2013-2018)
Figure Global Orphan Diseases Revenue Market Share by Regions in 2017
Figure North America Orphan Diseases Revenue and Growth Rate (2013-2018)
Figure Europe Orphan Diseases Revenue and Growth Rate (2013-2018)
Figure Asia-Pacific Orphan Diseases Revenue and Growth Rate (2013-2018)
Figure South America Orphan Diseases Revenue and Growth Rate (2013-2018)
Figure Middle East and Africa Orphan Diseases Revenue and Growth Rate (2013-2018)
Table North America Orphan Diseases Revenue by Countries (2013-2018)
Table North America Orphan Diseases Revenue Market Share by Countries (2013-2018)
Figure North America Orphan Diseases Revenue Market Share by Countries (2013-2018)
Figure North America Orphan Diseases Revenue Market Share by Countries in 2017
Figure USA Orphan Diseases Revenue and Growth Rate (2013-2018)
Figure Canada Orphan Diseases Revenue and Growth Rate (2013-2018)
Figure Mexico Orphan Diseases Revenue and Growth Rate (2013-2018)
Table Europe Orphan Diseases Revenue (Million USD) by Countries (2013-2018)
Figure Europe Orphan Diseases Revenue Market Share by Countries (2013-2018)
Figure Europe Orphan Diseases Revenue Market Share by Countries in 2017
Figure Germany Orphan Diseases Revenue and Growth Rate (2013-2018)
Figure UK Orphan Diseases Revenue and Growth Rate (2013-2018)
Figure France Orphan Diseases Revenue and Growth Rate (2013-2018)
Figure Russia Orphan Diseases Revenue and Growth Rate (2013-2018)
Figure Italy Orphan Diseases Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Orphan Diseases Revenue (Million USD) by Countries (2013-2018)
Figure Asia-Pacific Orphan Diseases Revenue Market Share by Countries (2013-2018)
Figure Asia-Pacific Orphan Diseases Revenue Market Share by Countries in 2017
Figure China Orphan Diseases Revenue and Growth Rate (2013-2018)
Figure Japan Orphan Diseases Revenue and Growth Rate (2013-2018)
Figure Korea Orphan Diseases Revenue and Growth Rate (2013-2018)
Figure India Orphan Diseases Revenue and Growth Rate (2013-2018)
Figure Southeast Asia Orphan Diseases Revenue and Growth Rate (2013-2018)
Table South America Orphan Diseases Revenue by Countries (2013-2018)
Table South America Orphan Diseases Revenue Market Share by Countries (2013-2018)
Figure South America Orphan Diseases Revenue Market Share by Countries (2013-2018)
Figure South America Orphan Diseases Revenue Market Share by Countries in 2017
Figure Brazil Orphan Diseases Revenue and Growth Rate (2013-2018)
Figure Argentina Orphan Diseases Revenue and Growth Rate (2013-2018)
Figure Colombia Orphan Diseases Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Orphan Diseases Revenue (Million USD) by Countries (2013-2018)
Table Middle East and Africa Orphan Diseases Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Orphan Diseases Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Orphan Diseases Revenue Market Share by Countries in 2017
Figure Saudi Arabia Orphan Diseases Revenue and Growth Rate (2013-2018)
Figure UAE Orphan Diseases Revenue and Growth Rate (2013-2018)
Figure Egypt Orphan Diseases Revenue and Growth Rate (2013-2018)
Figure Nigeria Orphan Diseases Revenue and Growth Rate (2013-2018)
Figure South Africa Orphan Diseases Revenue and Growth Rate (2013-2018)
Table Global Orphan Diseases Revenue (Million USD) by Type (2013-2018)
Table Global Orphan Diseases Revenue Share by Type (2013-2018)
Figure Global Orphan Diseases Revenue Share by Type (2013-2018)
Figure Global Orphan Diseases Revenue Share by Type in 2017
Table Global Orphan Diseases Revenue Forecast by Type (2018-2023)
Figure Global Orphan Diseases Market Share Forecast by Type (2018-2023)
Figure Global Autoimmune Disorders Revenue Growth Rate (2013-2018)
Figure Global Genetic Disorders Revenue Growth Rate (2013-2018)
Figure Global Blood Disorders Revenue Growth Rate (2013-2018)
Figure Global Cancer Revenue Growth Rate (2013-2018)
Figure Global Growth Disorder Revenue Growth Rate (2013-2018)
Figure Global Cardiovascular Diseases Revenue Growth Rate (2013-2018)
Figure Global Neurological Disorders Revenue Growth Rate (2013-2018)
Figure Global Respiratory Disorders Revenue Growth Rate (2013-2018)
Figure Global Digestive Disorders Revenue Growth Rate (2013-2018)
Figure Global Eye Disorders Revenue Growth Rate (2013-2018)
Table Global Orphan Diseases Revenue by Application (2013-2018)
Table Global Orphan Diseases Revenue Share by Application (2013-2018)
Figure Global Orphan Diseases Revenue Share by Application (2013-2018)
Figure Global Orphan Diseases Revenue Share by Application in 2017
Table Global Orphan Diseases Revenue Forecast by Application (2018-2023)
Figure Global Orphan Diseases Market Share Forecast by Application (2018-2023)
Figure Global Hospitals And Clinics Revenue Growth Rate (2013-2018)
Figure Global Research Laboratories Revenue Growth Rate (2013-2018)
Figure Global Orphan Diseases Revenue (Million USD) and Growth Rate Forecast (2018 -2023)
Table Global Orphan Diseases Revenue (Million USD) Forecast by Regions (2018-2023)
Figure Global Orphan Diseases Revenue Market Share Forecast by Regions (2018-2023)
Figure North America Orphan Diseases Revenue Market Forecast (2018-2023)
Figure Europe Orphan Diseases Revenue Market Forecast (2018-2023)
Figure Asia-Pacific Orphan Diseases Revenue Market Forecast (2018-2023)
Figure South America Orphan Diseases Revenue Market Forecast (2018-2023)
Figure Middle East and Africa Orphan Diseases Revenue Market Forecast (2018-2023)